secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORASURE TECHNOLOGIES INC (OSUR)
CIK:        0001116463
Form:       8-K
Filed at:   2022-11-08T23:59:59+00:00
Accession:  0000950170-22-023216
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OraSure posts record Q3 revenue of $116.5M, up 116% YoY; InteliSwab drives growth
--------------------------------------------------------------------------------

- GAAP net income $5.3M ($0.07 diluted EPS) vs. loss of $15.0M a year ago; non-GAAP EPS $0.13.
- InteliSwab COVID-19 test revenue $79.6M, up 85% sequentially; core diagnostics revenue +14% YoY.
- Q3 operating cash flow $16.3M positive vs. ($19.1M) in 2021; cash balance $101.6M.
- Q4 revenue guidance $95-100M (49-57% YoY growth); expects continued positive cash flow.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1116463/000095017022023216/0000950170-22-023216-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1116463/000095017022023216/osur-20221108.htm
  HTML page:      https://secwatch.observer/filing/0000950170-22-023216

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer